Mr. Barry Kurokawa has served as a member of our Board of Directors since the Company’s inception. Mr. Kurokawa is the Chief Executive Officer and Co-Founder of Dianomi Therapeutics, a biotech company initially focused on autoimmune diseases based on sustained release drug delivery technology. Mr. Kurokawa has been a professional investor focused on healthcare for over 25 years. He was a Senior Vice President and Senior Portfolio manager at INVESCO Funds Group, in charge of the firm’s healthcare funds with $1.5 billion in assets under management and over $100 million in private venture investments. He co-founded and was the principal portfolio manager of ProMed Management, one of the first healthcare crossover healthcare hedge funds investing in both private and public companies. He later founded BlackRiver Capital Management, a healthcare investment advisory and corporate consulting firm. He has sat on the Board of Directors of several public and private healthcare companies, including the Board of Anterios until its acquisition by Allergan. Mr. Kurokawa has a BS in business administration from California State University, Los Angeles, and an MBA from Loyola Marymount University.